$WYY
WIDEPOINT CORP

2023 Q2 Form 10-Q Financial Statement

#000165495423006572 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $26.76M $25.27M $23.34M
YoY Change 16.07% 12.65% -4.56%
Cost Of Revenue $22.85M $21.46M $19.78M
YoY Change 15.78% 15.77% -3.31%
Gross Profit $3.910M $3.810M $3.560M
YoY Change 17.77% -2.23% -10.93%
Gross Profit Margin 14.61% 15.07% 15.25%
Selling, General & Admin $4.373M $4.432M $4.032M
YoY Change -0.17% 2.59% -11.42%
% of Gross Profit 111.84% 116.34% 113.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $771.7K $265.8K $763.1K
YoY Change 181.56% 0.56% 47.45%
% of Gross Profit 19.74% 6.98% 21.44%
Operating Expenses $4.636M $4.698M $4.298M
YoY Change -77.85% 2.48% -10.64%
Operating Profit -$726.7K -$888.4K -$738.7K
YoY Change -95.87% 29.12% -9.22%
Interest Expense $56.91K $58.78K -$45.75K
YoY Change -9.42% -7.47% -29.54%
% of Operating Profit
Other Income/Expense, Net -$66.53K -$56.78K $380.1K
YoY Change -110.88% -123.26% -38.23%
Pretax Income -$793.3K -$945.2K -$404.3K
YoY Change -95.33% 112.89% 53.56%
Income Tax $48.81K $6.302K $8.488M
% Of Pretax Income
Net Earnings -$842.1K -$951.5K -$8.892M
YoY Change -93.88% 142.17% 1447.89%
Net Earnings / Revenue -3.15% -3.76% -38.1%
Basic Earnings Per Share -$0.11
Diluted Earnings Per Share -$0.10 -$0.11 -$1.02
COMMON SHARES
Basic Shares Outstanding 8.786M shares 8.725M shares 8.725M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.775M $4.578M $7.531M
YoY Change 8.11% -37.01% 16.22%
Cash & Equivalents $7.775M $4.578M $7.531M
Short-Term Investments
Other Short-Term Assets $1.105M $939.2K $936.0K
YoY Change -60.4% -66.18% -70.7%
Inventory $307.4K $239.7K $222.3K
Prepaid Expenses
Receivables $8.951M $10.20M $9.277M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $31.43M $27.56M $27.99M
YoY Change 3.78% -5.28% -15.57%
LONG-TERM ASSETS
Property, Plant & Equipment $888.9K $978.6K $978.2K
YoY Change -22.9% -22.31% 16.3%
Goodwill $5.812M $5.812M $5.812M
YoY Change 0.0% -73.69% -73.69%
Intangibles $6.673M $7.179M $7.398M
YoY Change 4.91% 18.77%
Long-Term Investments
YoY Change
Other Assets $2.425M $2.212M $2.026M
YoY Change -13.02% -69.84% 13.68%
Total Long-Term Assets $20.27M $20.83M $21.02M
YoY Change -31.2% -50.57% -50.34%
TOTAL ASSETS
Total Short-Term Assets $31.43M $27.56M $27.99M
Total Long-Term Assets $20.27M $20.83M $21.02M
Total Assets $51.71M $48.39M $49.01M
YoY Change -13.47% -32.07% -35.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.38M $13.58M $12.52M
YoY Change -8.96% 6.3% 21.94%
Accrued Expenses $13.85M $10.65M $11.33M
YoY Change 41.13% 24.91% -8.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $30.56M $26.42M $26.14M
YoY Change 12.78% 8.36% 0.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.884M $4.993M $5.118M
YoY Change -15.25% -18.78% -34.16%
Total Long-Term Liabilities $4.884M $4.993M $5.118M
YoY Change -15.25% -18.78% -34.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.56M $26.42M $26.14M
Total Long-Term Liabilities $4.884M $4.993M $5.118M
Total Liabilities $35.45M $31.42M $31.26M
YoY Change 7.86% 2.89% -7.55%
SHAREHOLDERS EQUITY
Retained Earnings -$84.90M -$84.05M -$83.10M
YoY Change 15.24% 39.63%
Common Stock $8.894K $8.740K $101.2M
YoY Change -99.99% -0.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.26M $16.97M $17.75M
YoY Change
Total Liabilities & Shareholders Equity $51.71M $48.39M $49.01M
YoY Change -13.47% -32.07% -35.07%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$842.1K -$951.5K -$8.892M
YoY Change -93.88% 142.17% 1447.89%
Depreciation, Depletion And Amortization $771.7K $265.8K $763.1K
YoY Change 181.56% 0.56% 47.45%
Cash From Operating Activities $3.510M -$2.489M $2.851M
YoY Change 159.16% -188.09% -160.88%
INVESTING ACTIVITIES
Capital Expenditures $358.7K $96.72K $345.6K
YoY Change -130.74% -52.42% -142.38%
Acquisitions
YoY Change
Other Investing Activities $143.1K $0.00
YoY Change -100.0%
Cash From Investing Activities -$215.5K -$359.3K -$345.6K
YoY Change -81.53% -63.48% -93.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -129.9K -$129.2K -153.7K
YoY Change -13.27% -87.27% -88.91%
NET CHANGE
Cash From Operating Activities 3.510M -$2.489M 2.851M
Cash From Investing Activities -215.5K -$359.3K -345.6K
Cash From Financing Activities -129.9K -$129.2K -153.7K
Net Change In Cash 3.165M -$2.953M 2.352M
YoY Change 8278.69% -474.85% -120.32%
FREE CASH FLOW
Cash From Operating Activities $3.510M -$2.489M $2.851M
Capital Expenditures $358.7K $96.72K $345.6K
Free Cash Flow $3.151M -$2.586M $2.505M
YoY Change 24.99% -198.61% -164.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Depreciation
Depreciation
267309 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
35858 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17294 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-15790 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
113869 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
262549 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-359270 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
125568 usd
CY2023Q1 wyy Withholding Taxes Paid On Behalf Of Employees On Net Settled Restricted Stock Awards
WithholdingTaxesPaidOnBehalfOfEmployeesOnNetSettledRestrictedStockAwards
3628 usd
CY2023Q1 wyy Common Stock Repurchased
CommonStockRepurchased
0 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
18539702 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001034760
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2045714 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8725476 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8739317 shares
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
40 usd
CY2023Q1 us-gaap Proceeds From Grantors
ProceedsFromGrantors
74310 usd
CY2022Q4 wyy Preferred Stock Par Value
PreferredStockParValue
0.001
CY2022Q4 wyy Common Stock Par Value
CommonStockParValue
0.001
CY2022Q1 us-gaap Interest Income Other
InterestIncomeOther
6570 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
58778 usd
CY2023Q1 wyy Common Stock Par Value
CommonStockParValue
0.001
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
100687 shares
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
62700 usd
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
110000 usd
CY2022Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-33035
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
WidePoint Corporation
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2040275
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
11250 Waples Mill Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
South Tower 210
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Fairfax
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
22030
CY2023Q1 dei City Area Code
CityAreaCode
703
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
349-2577
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
WYY
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8785616 shares
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
502560 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
287518 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
3896725 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
575169 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
140116 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
179741 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3910820 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3745229 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
265843 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
264361 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
4698341 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
4584759 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-888401 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-688034 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
2196 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
63521 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-194 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
301013 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-56776 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
244062 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-945177 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-443972 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6302 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-51075 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-951479 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-392897 usd
CY2023Q1 wyy Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.11
CY2022Q1 wyy Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.04
CY2023Q1 wyy Weighted Average Number Of Share Outstanding Basic
WeightedAverageNumberOfShareOutstandingBasic
8739317 shares
CY2022Q1 wyy Weighted Average Number Of Share Outstanding Basic
WeightedAverageNumberOfShareOutstandingBasic
8782452 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-951479 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-392897 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
37248 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4835 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
37248 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4835 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-914231 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-397732 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4577963 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7530864 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10202272 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9277109 usd
CY2023Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
11843638 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
10244101 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
939187 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
935978 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
27563060 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
27988052 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
978633 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
978218 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4556571 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4723899 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7179206 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7398160 usd
CY2023Q1 us-gaap Goodwill
Goodwill
5811578 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5811578 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
88360 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
86909 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2211695 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2025845 usd
CY2023Q1 us-gaap Assets
Assets
48389103 usd
CY2022Q4 us-gaap Assets
Assets
49012661 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
13584437 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12515081 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10652753 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11327269 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1579040 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1704933 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
606055 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
596529 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
26422285 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26143812 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4610296 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4745909 usd
CY2023Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
6900 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
6900 usd
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
376162 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
364837 usd
CY2023Q1 us-gaap Liabilities
Liabilities
31415643 usd
CY2022Q4 us-gaap Liabilities
Liabilities
31261458 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
8740 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
8726 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101330659 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101194185 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-312986 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-350234 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84052953 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-83101474 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
16973460 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17751203 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48389103 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49012661 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
951479 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
392897 usd
CY2022Q1 us-gaap Depreciation
Depreciation
265185 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
501094 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
286653 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
140116 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
179741 usd
CY2023Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
0 usd
CY2022Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
108000 usd
CY2023Q1 wyy Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
0 usd
CY2022Q1 wyy Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
301000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2528761 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4413557 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-311218 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
55703 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-121253 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2489048 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
96721 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-983873 usd
CY2023Q1 wyy Advances On Bank Line Of Credit
AdvancesOnBankLineOfCredit
-4313007 usd
CY2022Q1 wyy Advances On Bank Line Of Credit
AdvancesOnBankLineOfCredit
0 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
4313007 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
147405 usd
CY2022Q1 wyy Withholding Taxes Paid On Behalf Of Employees On Net Settled Restricted Stock Awards
WithholdingTaxesPaidOnBehalfOfEmployeesOnNetSettledRestrictedStockAwards
49224 usd
CY2022Q1 wyy Common Stock Repurchased
CommonStockRepurchased
818211 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-129196 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24613 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-38950 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2952901 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7530864 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
55979 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
27559 usd
CY2023Q1 wyy Capitalized Hardware And Software Development Costs In Accounts Payable Mgkhg
CapitalizedHardwareAndSoftwareDevelopmentCostsInAccountsPayableMgkhg
190773 usd
CY2022Q1 wyy Capitalized Hardware And Software Development Costs In Accounts Payable Mgkhg
CapitalizedHardwareAndSoftwareDevelopmentCostsInAccountsPayableMgkhg
213770 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
876281 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41675995 usd
CY2022Q1 wyy Common Stock Repurchased Shares
CommonStockRepurchasedShares
-818211 usd
CY2022Q1 wyy Restricted Amount
RestrictedAmount
-49224 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
108000 usd
CY2022Q1 wyy Stock Issued During Period Restricted Amount
StockIssuedDuringPeriodRestrictedAmount
179741 usd
CY2022Q1 wyy Stock Issued During Period Foreign Currency Translation Gain Loss Amount
StockIssuedDuringPeriodForeignCurrencyTranslationGainLossAmount
-4835 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-392897 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
40698569 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17751203 usd
CY2023Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-3628 usd
CY2023Q1 wyy Stock Issued During Period Restricted Amount
StockIssuedDuringPeriodRestrictedAmount
140116 usd
CY2023Q1 wyy Foreign Currency Translation Gain
ForeignCurrencyTranslationGain
37248 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-951479 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
16973460 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring use of estimates and judgment relate to revenue recognition, allowance for credit losses, ability to realize intangible assets and goodwill, ability to realize deferred income tax assets, fair value of certain financial instruments and the evaluation of contingencies and litigation. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates. There were no significant changes in accounting estimates used by management during the quarter.</p>
CY2023Q1 wyy Significant Accounting Policies
SignificantAccountingPolicies
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">There were no significant changes in the Company’s significant accounting policies during the first three months of 2023 from those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 31, 2023.</p>
CY2023Q1 wyy Contingent Consideration Cash Settled
ContingentConsiderationCashSettled
6500 usd
CY2022Q4 wyy Contingent Consideration Cash Settled
ContingentConsiderationCashSettled
6500 usd
CY2023Q1 wyy Contingent Consideration Warrants
ContingentConsiderationWarrants
400 usd
CY2022Q4 wyy Contingent Consideration Warrants
ContingentConsiderationWarrants
400 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6900 usd
CY2023Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6900 usd
CY2023Q1 wyy Contingent Consideration Cash Settled
ContingentConsiderationCashSettled
6500 usd
CY2022Q4 wyy Contingent Consideration Cash Settled
ContingentConsiderationCashSettled
6500 usd
CY2023Q1 wyy Contingent Consideration Warrants
ContingentConsiderationWarrants
400 usd
CY2022Q4 wyy Contingent Consideration Warrants
ContingentConsiderationWarrants
400 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6900 usd
CY2023Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6900 usd
CY2023Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
10274543 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
9328775 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
72271 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
51666 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
10202272 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
9277109 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
239658 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
222279 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
699529 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
713699 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
939187 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
935978 usd
CY2023Q1 wyy Carrier Service Costs
CarrierServiceCosts
8159230 usd
CY2022Q1 wyy Carrier Service Costs
CarrierServiceCosts
8402770 usd
CY2023Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1609058 usd
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1637628 usd
CY2023Q1 us-gaap Other Inventory Purchased Goods
OtherInventoryPurchasedGoods
746113 usd
CY2022Q1 us-gaap Other Inventory Purchased Goods
OtherInventoryPurchasedGoods
1205209 usd
CY2023Q1 wyy Income Tax Payable
IncomeTaxPayable
61490 usd
CY2022Q1 wyy Income Tax Payable
IncomeTaxPayable
61490 usd
CY2023Q1 wyy Other Accrued Expenses
OtherAccruedExpenses
76862 usd
CY2022Q1 wyy Other Accrued Expenses
OtherAccruedExpenses
20172 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10652753 usd
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11327269 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4184486 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4067664 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3205853 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3089446 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
978633 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
978218 usd
CY2023Q1 wyy Property And Equipment Depreciation Expense
PropertyAndEquipmentDepreciationExpense
116400 usd
CY2022Q1 wyy Property And Equipment Depreciation Expense
PropertyAndEquipmentDepreciationExpense
93700 usd
CY2023Q1 us-gaap Goodwill
Goodwill
5811578 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12299070 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5119864 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7179206 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12016509 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4618349 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7398160 usd
CY2023Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
453300 usd
CY2022Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
820000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
501100 usd
CY2022Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
286700 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1497301 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1797411 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1123850 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
526714 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
511170 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1722760 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7179206 usd
CY2023Q1 wyy Net Paid Percentage
NetPaidPercentage
0.90 pure
CY2023Q1 wyy Description Related To Line Of Credit
DescriptionRelatedToLineOfCredit
The facility is limited to a total of $4 million outstanding at any time, with an available increase to $10 million, subject to adequate receivables
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.007 pure
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.115 pure
CY2023Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
23800000000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q1 wyy Common Stock Share Issued
CommonStockShareIssued
8741310 shares
CY2022Q4 wyy Common Stock Share Issued
CommonStockShareIssued
50345 shares
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
49300 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
140300 shares
CY2023Q1 us-gaap Insured Financial Obligations With Credit Deterioration Remaining Weighted Average Contract Period
InsuredFinancialObligationsWithCreditDeteriorationRemainingWeightedAverageContractPeriod
P1Y
CY2023Q1 us-gaap Revenues
Revenues
25273681 usd
CY2022Q1 us-gaap Revenues
Revenues
22436427 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-951479 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-392897 usd
CY2023Q1 wyy Weighted Average Number Of Common Shares
WeightedAverageNumberOfCommonShares
8739317 shares
CY2022Q1 wyy Weighted Average Number Of Common Shares
WeightedAverageNumberOfCommonShares
8782452 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q1 wyy Net Loss Income Diluted
NetLossIncomeDiluted
-951479 usd
CY2022Q1 wyy Net Loss Income Diluted
NetLossIncomeDiluted
-392897 usd
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8739317 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8782452 shares
CY2023Q1 wyy Adjustments Weighted Average Number Of Common Shares
AdjustmentsWeightedAverageNumberOfCommonShares
8739317 shares
CY2022Q1 wyy Adjustments Weighted Average Number Of Common Shares
AdjustmentsWeightedAverageNumberOfCommonShares
8782452 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
34682 shares
CY2022Q1 us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
30513 shares
CY2023Q1 wyy Warrantsto Purchasec Cmmon Shares Outstanding
WarrantstoPurchasecCmmonSharesOutstanding
150000 shares
CY2022Q1 wyy Warrantsto Purchasec Cmmon Shares Outstanding
WarrantstoPurchasecCmmonSharesOutstanding
150000 shares
CY2023Q1 us-gaap Revenues
Revenues
25273681 usd
CY2022Q1 us-gaap Revenues
Revenues
22436427 usd
CY2023Q1 us-gaap Revenues
Revenues
25273681 usd
CY2022Q1 us-gaap Revenues
Revenues
22436427 usd
CY2023Q1 wyy Revenue Related Approximately
RevenueRelatedApproximately
709400 usd
CY2022Q1 wyy Revenue Related Approximately
RevenueRelatedApproximately
1079900 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
wyy-20230331_cal.xml Edgar Link unprocessable
0001654954-23-006572-index-headers.html Edgar Link pending
0001654954-23-006572-index.html Edgar Link pending
0001654954-23-006572.txt Edgar Link pending
0001654954-23-006572-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wyy-20230331.xsd Edgar Link pending
wyy_10q.htm Edgar Link pending
wyy_ex311.htm Edgar Link pending
wyy_ex312.htm Edgar Link pending
wyy_ex32.htm Edgar Link pending
wyy-20230331_def.xml Edgar Link unprocessable
wyy-20230331_lab.xml Edgar Link unprocessable
wyy-20230331_pre.xml Edgar Link unprocessable
wyy_10q_htm.xml Edgar Link completed